Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
AU StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARTRYA LTD

1.100
-0.025-2.22%
Volume:228.35K
Turnover:254.88K
Market Cap:125.08M
PE:-6.05
High:1.155
Open:1.150
Low:1.065
Close:1.125
Loading ...
OverviewCompanyNewsFilings

Artrya Responds to US Drug Watchdog's Queries for its Coronary Anatomy Product

MT Newswires Live
·
28 Feb

BRIEF-Artrya Reports HY Loss From Ordinary Activities After Tax Attributable A$7.4 Mln

Reuters
·
25 Feb

BUZZ-Australia's Artrya slips most in over 2 weeks on discounted placement

Reuters
·
14 Feb

BRIEF-Artrya Announces A$15 Million Placement

Reuters
·
14 Feb

Artrya Ltd-Proposed Issue of Securities - Aya

THOMSON REUTERS
·
14 Feb

Artrya Ltd - a$15 Mln Placement at a$0.73 per Share

THOMSON REUTERS
·
14 Feb

BRIEF-Artrya Secures Multi-Year Contract With Sonic Healthcare

Reuters
·
12 Feb

Artrya Signs Commercial Contract with Sonic Healthcare for Coronary Artery Disease Assessment Platform

MT Newswires Live
·
12 Feb

Artrya Ltd - Contract for Use of Salix Coronary Anatomy Platform

THOMSON REUTERS
·
12 Feb

ASX Alert-Aya Secures Multi-Year Contract With Sonic Healthcare-Aya.ax

THOMSON REUTERS
·
12 Feb

Artrya Ltd - Artrya Secures Multi-Year Commercial Contract With Sonic Healthcare Australia

THOMSON REUTERS
·
12 Feb

BRIEF-Artrya Ltd Seeks Trading Halt

Reuters
·
12 Feb

Corporate Actions

no data

No relevant data is available

Dividend History

no data

No relevant data is available

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.